[Effectiveness-risk ratio of heparin-dihydroergotamine].
D004087:Dihydroergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005268:Femoral Vein; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D013924:Thrombophlebitis / Q000188:drug therapy*
D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; C031388:heparin-dihydergot; D004087:Dihydroergotamine; D006493:Heparin
Nutzen-Risiko-Dimension von Heparin-Dihydroergotamin.